Zeng YF - Search Results

1

Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.

Zeng YF, Xiao YS, Lu MZ, Luo XJ, Hu GZ, Deng KY, Wu XM, Xin HB. Zeng YF, et al. Exp Mol Pathol. 2015 Apr;98(2):260-7. doi: 10.1016/j.yexmp.2015.03.008. Epub 2015 Mar 7. Exp Mol Pathol. 2015. PMID: 25758200

2

Formin-like 3 regulates RhoC/FAK pathway and actin assembly to promote cell invasion in colorectal carcinoma.

Zeng YF, Xiao YS, Liu Y, Luo XJ, Wen LD, Liu Q, Chen M. Zeng YF, et al. World J Gastroenterol. 2018 Sep 14;24(34):3884-3897. doi: 10.3748/wjg.v24.i34.3884. World J Gastroenterol. 2018. PMID: 30228782 Free PMC article.

3

CircFADS2: A potential prognostic biomarker of colorectal cancer.

Xiao YS, Tong HZ, Yuan XH, Xiong CH, Xu XY, Zeng YF. Xiao YS, et al. Among authors: zeng yf. Exp Biol Med (Maywood). 2020 Aug;245(14):1233-1241. doi: 10.1177/1535370220929965. Epub 2020 Jun 2. Exp Biol Med (Maywood). 2020. PMID: 32486849 Free PMC article.

4

FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma.

Zhu XL, Zeng YF, Guan J, Li YF, Deng YJ, Bian XW, Ding YQ, Liang L. Zhu XL, et al. Among authors: zeng yf. J Pathol. 2011 Jul;224(3):377-88. doi: 10.1002/path.2871. Epub 2011 Apr 19. J Pathol. 2011. PMID: 21506128

5

Down-regulation of formin-like 2 predicts poor prognosis in hepatocellular carcinoma.

Liang L, Guan J, Zeng Y, Wang J, Li X, Zhang X, Ding Y. Liang L, et al. Hum Pathol. 2011 Nov;42(11):1603-12. doi: 10.1016/j.humpath.2010.08.025. Epub 2011 Apr 14. Hum Pathol. 2011. PMID: 21496865

6

Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.

Li X, Wang J, Zhang X, Zeng Y, Liang L, Ding Y. Li X, et al. Ann Surg Oncol. 2012 Jan;19(1):145-53. doi: 10.1245/s10434-011-1944-4. Epub 2011 Aug 23. Ann Surg Oncol. 2012. PMID: 21861235

7

Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.

Zeng Y, Xie H, Qiao Y, Wang J, Zhu X, He G, Li Y, Ren X, Wang F, Liang L, Ding Y. Zeng Y, et al. Cancer Sci. 2015 Oct;106(10):1385-93. doi: 10.1111/cas.12768. Cancer Sci. 2015. Retraction in: Cancer Sci. 2016 Jul;107(7):1060. doi: 10.1111/cas.12972 PMID: 26258642 Free PMC article. Retracted.

8

FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.

Li Y, Zhu X, Zeng Y, Wang J, Zhang X, Ding YQ, Liang L. Li Y, et al. Mol Cancer Res. 2010 Dec;8(12):1579-90. doi: 10.1158/1541-7786.MCR-10-0081. Epub 2010 Nov 11. Mol Cancer Res. 2010. PMID: 21071512

9

Novel TRERF1 mutations in Chinese patients with ovarian endometriosis.

Cao B, Zeng Y, Wu F, Liu J, Shuang Z, Xu X, Guo J. Cao B, et al. Mol Med Rep. 2018 Apr;17(4):5435-5439. doi: 10.3892/mmr.2018.8510. Epub 2018 Jan 26. Mol Med Rep. 2018. PMID: 29393434

10

Mammary-type myofibroblastoma with infarction and atypical mitosis-a potential diagnostic pitfall: A case report.

Zeng YF, Dai YZ, Chen M. Zeng YF, et al. World J Clin Cases. 2022 Jun 6;10(16):5343-5351. doi: 10.12998/wjcc.v10.i16.5343. World J Clin Cases. 2022. PMID: 35812659 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters